4TEEN4 Pharmaceuticals GmbH
PrivateLast Round
Grant
Jul 2, 2026
Est. Valuation
$190.91M
Total Funding Raised
$103.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
4TEEN4 Pharmaceuticals GmbH is a biotechnology company that develops precision medicine therapies and diagnostic assays for the treatment of acute cardiovascular complications and circulatory shock.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
4TEEN4 Pharmaceuticals GmbH Comparables
Compare 4TEEN4 Pharmaceuticals GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adrenomed AG | 80% | |
| Inotrem | 79% | |
| Pharmazz, Inc. | 78% | |
4TEEN4 Pharmaceuticals GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 2, 2026 | ||||
| Grant | Jun 17, 2026 | ||||
| Series C Extension | Mar 10, 2026 | ||||
| Grant | Feb 29, 2024 | ||||
| Strategic | Feb 21, 2024 | ||||
Series B | Feb 21, 2024 |
Key People
Founding team and executive leadership
4TEEN4 Pharmaceuticals GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brandenburg Kapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Secured $3.65M in grant funding.
- Jun 17, 2026
$9.27M grant received from Horizon Europe.
4TEEN4 Pharmaceuticals GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 4TEEN4 Pharmaceuticals GmbH's valuation, stock price, and market status.